Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2023 Earnings Call Transcript

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2023 Earnings Call Transcript February 22, 2024

Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.07 EPS, expectations were $0.2. Amylyx Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good morning. My name is Jenny, and I will be your conference operator today. At this time, I would like to welcome everyone to the...